IBA receives 1st payment from Chinese licensing deal
September 24, 2020 -- Proton therapy developer Ion Beam Applications (IBA) has received the first payment of 20 million euros ($23.3 million U.S.) from its strategic licensing deal with CGN Nuclear Technology Development in China.
Radiation tied to breast cancer delays for Black women
September 21, 2020 -- Black women with breast cancer may be more likely to experience treatment delays and longer treatment times than white women, according to the findings of a study published on September 21 in Cancer. This was particularly true for Black women who opted for radiation as part of their treatment.  Discuss
CMS releases new payment model for radiation oncology
September 18, 2020 -- The U.S. Centers for Medicare and Medicaid Services (CMS) today released its long-awaited Radiation Oncology Model, an alternative method for the agency to pay for radiation therapy procedures in the Medicare and Medicaid systems.  Discuss
New CMS payment model doesn't cover iCAD's rad therapy
September 18, 2020 -- Computer-aided detection (CAD) software developer iCAD said the U.S. Center for Medicare and Medicaid Services' (CMS) new Radiation Oncology Model, an alternative payment model, does not include coverage for iCAD's intraoperative radiation therapy.
Radiation Business solutions purchases Radmax
September 18, 2020 -- Radiation Business Solutions purchased Radmax, a radiation oncology medical billing company headquartered in Tyler, TX.
China extends tariff exclusion for Varian for a year
September 16, 2020 -- Radiation therapy vendor Varian Medical Systems will remain exempt from paying additional tariffs to China on the company's medical linear accelerators for another year.
Q BioMed reports sales progress with Strontium89
September 15, 2020 -- Biotech company Q BioMed is reporting sales progress from the launch of its Strontium89 (strontium-89 chloride injection) metastatic bone cancer palliation radiopharmaceutical.
Varian releases update to proton therapy software
September 15, 2020 -- Varian Medical Systems has received 510(k) clearance from the U.S. Food and Drug Administration for the latest version of its Eclipse proton therapy planning software.
FDA grants rare disease designation to Clarity agent
September 10, 2020 -- Radiopharmaceutical firm Clarity Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted rare pediatric disease designation to its radiopharmaceutical for neuroblastoma.
Isotopia, CPDC ink manufacturing deal for lutetium-177
September 8, 2020 -- Isotopia Molecular Imaging of Israel has signed a production agreement for no-carrier-added lutetium-177 with radiopharmaceutical manufacturer Centre for Probe Development and Commercialization (CPDC) of Canada.
Special Feature
IMV: Imaging boosts precision in radiation therapy

Radiation therapy is a relatively stable market, with procedure volume growing at an average annual rate of 2%. But major technological changes in radiation oncology are brewing under the surface, according to a new report by IMV Medical Information Division. Read more